Summary

for people ages 18 years and up (full criteria)
at La Jolla, California and other locations
study started
estimated completion

Description

Summary

The purpose of this study is to assess the long-term safety and tolerability of ABBV-8E12 in subjects with progressive supranuclear palsy (PSP).

Keywords

Progressive Supranuclear Palsy (PSP) Supranuclear Palsy, Progressive ABBV-8E12

Eligibility

You can join if…

Open to people ages 18 years and up

  • Subject completed Study C2N-8E12-WW-104 (NCT02494024)
  • Subject was not eligible to enroll in Study M15-562 (NCT02985879)

You CAN'T join if...

  • Subject weighs less than 35 kg at screening
  • Subject has any contraindication or inability to tolerate brain MRI
  • Subject has any significant change in his/her medical condition that could interfere with the subject's participation in the study, could place the subject at increased risk, or could confound interpretation of study results

Locations

  • University of California, San Diego /ID# 170113
    La Jolla California 92093 United States
  • Kerwin Research Center /ID# 170112
    Dallas Texas 75218 United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
AbbVie
ID
NCT03413319
Phase
Phase 1
Study Type
Interventional
Last Updated